{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:28:56Z","timestamp":1768570136298,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00120-021-01491-y","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T12:02:46Z","timestamp":1615809766000},"page":"567-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Famili\u00e4res Prostatakarzinom und genetische Pr\u00e4disposition","Familial prostate cancer and genetic predisposition"],"prefix":"10.1007","volume":"60","author":[{"given":"V. H.","family":"Meissner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jahnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Herkommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"1491_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jnci\/89.4.287","volume":"89","author":"A Ahlbom","year":"1997","unstructured":"Ahlbom\u00a0A, Lichtenstein\u00a0P, Malmstr\u00f6m\u00a0H et\u00a0al (1997) Cancer in twins: genetic and nongenetic familial risk factors. J\u00a0Natl Cancer Inst 89:287\u2013293","journal-title":"J Natl Cancer Inst"},{"key":"1491_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.radonc.2013.11.014","volume":"110","author":"H Bagshaw","year":"2014","unstructured":"Bagshaw\u00a0H, Ruth\u00a0K, Horwitz\u00a0EM et\u00a0al (2014) Does family history of prostate cancer affect outcomes following radiotherapy? Radiother Oncol 110:229\u2013234","journal-title":"Radiother Oncol"},{"key":"1491_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.eururo.2014.01.003","volume":"66","author":"EK Bancroft","year":"2014","unstructured":"Bancroft\u00a0EK, Page\u00a0EC, Castro\u00a0E et\u00a0al (2014) Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. Eur Urol 66:489\u2013499","journal-title":"Eur Urol"},{"key":"1491_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford\u00a0AN, Jackson\u00a0SP (2017) ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell 66:801\u2013817","journal-title":"Mol Cell"},{"key":"1491_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.eururo.2010.02.002","volume":"58","author":"A Brandt","year":"2010","unstructured":"Brandt\u00a0A, Bermejo\u00a0JL, Sundquist\u00a0J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275\u2013280","journal-title":"Eur Urol"},{"key":"1491_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.juro.2015.07.097","volume":"195","author":"JM Brath","year":"2016","unstructured":"Brath\u00a0JM, Grill\u00a0S, Ankerst\u00a0DP et al (2016) No detrimental effect of a\u00a0positive family history on long-term outcomes following radical prostatectomy. J\u00a0Urol 195:343\u2013348","journal-title":"J Urol"},{"key":"1491_CR7","doi-asserted-by":"publisher","unstructured":"Bratt O, Drevin L, Akre O et al (2016) Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study. J\u00a0Natl Cancer Inst 108(10):djw110. https:\/\/doi.org\/10.1093\/jnci\/djw110","DOI":"10.1093\/jnci\/djw110"},{"key":"1491_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0022-5347(17)35617-3","volume":"150","author":"BS Carter","year":"1993","unstructured":"Carter\u00a0BS, Bova\u00a0GS, Beaty\u00a0TH et\u00a0al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J\u00a0Urol 150:797\u2013802","journal-title":"J Urol"},{"key":"1491_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6004\/jnccn.2019.7307","volume":"17","author":"HH Cheng","year":"2019","unstructured":"Cheng\u00a0HH, Sokolova\u00a0AO, Schaeffer\u00a0EM et\u00a0al (2019) Germline and somatic mutations in prostate cancer for the clinician. J\u00a0Natl Compr Canc Netw 17:515\u2013521","journal-title":"J Natl Compr Canc Netw"},{"key":"1491_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1086\/346094","volume":"72","author":"X Dong","year":"2003","unstructured":"Dong\u00a0X, Wang\u00a0L, Taniguchi\u00a0K et\u00a0al (2003) Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 72:270\u2013280","journal-title":"Am J Hum Genet"},{"key":"1491_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-020-15122-1","volume":"11","author":"WD Dupont","year":"2020","unstructured":"Dupont\u00a0WD, Breyer\u00a0JP, Plummer\u00a0WD et\u00a0al (2020) 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer. Nat Commun 11:1523","journal-title":"Nat Commun"},{"key":"1491_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1110000","volume":"366","author":"CM Ewing","year":"2012","unstructured":"Ewing\u00a0CM, Ray\u00a0AM, Lange\u00a0EM et al (2012) Germline mutations in HOXB13 and prostate-cancer risk. N\u00a0Engl J Med 366:141\u2013149","journal-title":"N Engl J Med"},{"key":"1491_CR13","first-page":"4513","volume":"60","author":"SA Gayther","year":"2000","unstructured":"Gayther\u00a0SA, De Foy\u00a0KA, Harrington\u00a0P et al (2000) The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign\/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Res 60:4513\u20134518","journal-title":"Cancer Res"},{"key":"1491_CR14","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1158\/1055-9965.EPI-09-0058","volume":"18","author":"EM Grindedal","year":"2009","unstructured":"Grindedal\u00a0EM, M\u00f8ller\u00a0P, Eeles\u00a0R et al (2009) Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomarkers Prev 18:2460\u20132467","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1491_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1947601910381380","volume":"1","author":"C Grisanzio","year":"2010","unstructured":"Grisanzio\u00a0C, Freedman\u00a0ML (2010) Chromosome 8q24-associated cancers and MYC. Genes Cancer 1:555\u2013559","journal-title":"Genes Cancer"},{"key":"1491_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00345-011-0801-1","volume":"30","author":"K Hemminki","year":"2012","unstructured":"Hemminki\u00a0K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143\u2013148","journal-title":"World J Urol"},{"key":"1491_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/annonc\/mdm414","volume":"19","author":"K Hemminki","year":"2008","unstructured":"Hemminki\u00a0K, Sundquist\u00a0J, Bermejo\u00a0JL (2008) How common is familial cancer? Ann Oncol 19:163\u2013167","journal-title":"Ann Oncol"},{"key":"1491_CR18","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00120-014-3617-y","volume":"53","author":"K Herkommer","year":"2014","unstructured":"Herkommer\u00a0K, Heimpel\u00a0M, Gschwend\u00a0JE (2014) Familial prostate cancer research: meaningfulness of hereditary criteria in view of demographic change. Urologe\u00a0A 53:1779\u20131785","journal-title":"Urologe A"},{"key":"1491_CR19","doi-asserted-by":"publisher","unstructured":"Herkommer K, Maier N, Ankerst DP et al (2020) No detrimental effect of a\u00a0positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance. World J Urol. https:\/\/doi.org\/10.1007\/s00345-020-03485-5","DOI":"10.1007\/s00345-020-03485-5"},{"key":"1491_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00120-011-2552-4","volume":"50","author":"K Herkommer","year":"2011","unstructured":"Herkommer\u00a0K, Schmidt\u00a0C, Gschwend\u00a0JE (2011) Ten years national research project \u201efamilial prostate cancer\u201c: problems in identifying risk families. Urologe\u00a0A 50:813\u2013820","journal-title":"Urologe A"},{"key":"1491_CR21","doi-asserted-by":"publisher","first-page":"i206","DOI":"10.1093\/bioinformatics\/btv240","volume":"31","author":"F Hormozdiari","year":"2015","unstructured":"Hormozdiari\u00a0F, Kichaev\u00a0G, Yang\u00a0WY et\u00a0al (2015) Identification of causal genes for complex traits. Bioinformatics 31:i206\u2013213","journal-title":"Bioinformatics"},{"key":"1491_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/sj.bjc.6604847","volume":"100","author":"Z Kote-Jarai","year":"2009","unstructured":"Kote-Jarai\u00a0Z, Jugurnauth\u00a0S, Mulholland\u00a0S et al (2009) A recurrent truncating germline mutation in the BRIP1\/FANCJ gene and susceptibility to prostate cancer. Br J Cancer 100:426\u2013430","journal-title":"Br J Cancer"},{"key":"1491_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1158\/1055-9965.EPI-12-1000-T","volume":"22","author":"VH Laitinen","year":"2013","unstructured":"Laitinen\u00a0VH, Wahlfors\u00a0T, Saaristo\u00a0L et al (2013) HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 22:452\u2013460","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1491_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41391-017-0018-5","volume":"21","author":"RRN Le\u00e3o","year":"2018","unstructured":"Le\u00e3o\u00a0RRN, Price\u00a0AJ, James Hamilton\u00a0R (2018) Germline BRCA mutation in male carriers-ripe for precision oncology? Prostate Cancer Prostatic Dis 21:48\u201356","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1491_CR25","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/bjc.2014.30","volume":"110","author":"D Leongamornlert","year":"2014","unstructured":"Leongamornlert\u00a0D, Saunders\u00a0E, Dadaev\u00a0T et\u00a0al (2014) Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br J Cancer 110:1663\u20131672","journal-title":"Br J Cancer"},{"key":"1491_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.juro.2016.07.004","volume":"197","author":"L Liesenfeld","year":"2017","unstructured":"Liesenfeld\u00a0L, Kron\u00a0M, Gschwend\u00a0JE et\u00a0al (2017) Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy. J\u00a0Urol 197:143\u2013148","journal-title":"J Urol"},{"key":"1491_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/pros.22552","volume":"73","author":"X Lin","year":"2013","unstructured":"Lin\u00a0X, Qu\u00a0L, Chen\u00a0Z et\u00a0al (2013) A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Prostate 73:169\u2013175","journal-title":"Prostate"},{"key":"1491_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG Macarthur","year":"2014","unstructured":"Macarthur\u00a0DG, Manolio\u00a0TA, Dimmock\u00a0DP et\u00a0al (2014) Guidelines for investigating causality of sequence variants in human disease. Nature 508:469\u2013476","journal-title":"Nature"},{"key":"1491_CR29","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1038\/s41467-018-06863-1","volume":"9","author":"M Matejcic","year":"2018","unstructured":"Matejcic\u00a0M, Saunders\u00a0EJ, Dadaev\u00a0T et\u00a0al (2018) Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nat Commun 9:4616","journal-title":"Nat Commun"},{"key":"1491_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000504789","volume":"104","author":"VH Meissner","year":"2020","unstructured":"Meissner\u00a0VH, Bittner\u00a0R, Kron\u00a0M et al (2020) Impact of a\u00a0changing population structure and clustering of cancer in prostate cancer patients depending on a\u00a0first-degree family history. Urol Int 104:222\u2013229","journal-title":"Urol Int"},{"key":"1491_CR31","doi-asserted-by":"crossref","unstructured":"Meissner VH, Str\u00fch JGH, Kron M et al (2020) The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy. World J Urol 38(12):3091\u20133099","DOI":"10.1007\/s00345-020-03147-6"},{"key":"1491_CR32","series-title":"Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","first-page":"479","volume-title":"Prostate Cancer","author":"JL Mohler","year":"2019","unstructured":"Mohler\u00a0JL, Antonarakis\u00a0ES, Armstrong\u00a0AJ et\u00a0al (2019) Prostate Cancer. Version 2.2019, NCCN Clinical Practice Guidelines in Oncology, Bd. 17, S\u00a0479"},{"key":"1491_CR33","doi-asserted-by":"crossref","unstructured":"Mottet N, Van Den Bergh RCN, Briers E et al (2020) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243\u2013262","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"1491_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.eururo.2019.08.025","volume":"77","author":"T Nyberg","year":"2020","unstructured":"Nyberg\u00a0T, Frost\u00a0D, Barrowdale\u00a0D et\u00a0al (2020) Prostate cancer risks for Male BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Eur Urol 77:24\u201335","journal-title":"Eur Urol"},{"key":"1491_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<240::AID-PROS3>3.0.CO;2-L","volume":"33","author":"WF Page","year":"1997","unstructured":"Page\u00a0WF, Braun\u00a0MM, Partin\u00a0AW et\u00a0al (1997) Heredity and prostate cancer: a\u00a0study of World War II veteran twins. Prostate 33:240\u2013245","journal-title":"Prostate"},{"key":"1491_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0302-2838(03)00146-5","volume":"43","author":"T Paiss","year":"2003","unstructured":"Paiss\u00a0T, Herkommer\u00a0K, Bock\u00a0B et\u00a0al (2003) Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615\u2013621","journal-title":"Eur Urol"},{"key":"1491_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00120-005-0780-1","volume":"44","author":"T Paiss","year":"2005","unstructured":"Paiss\u00a0T, Kahn\u00a0D, K\u00fcfer\u00a0R et\u00a0al (2005) Is the prostate cancer screening behaviour of men with familial predisposition predictable? Urologe\u00a0A 44:387\u2013392","journal-title":"Urologe A"},{"key":"1491_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli\u00a0N, Daly\u00a0MB, Feldman\u00a0GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med 12:245\u2013259","journal-title":"Genet Med"},{"key":"1491_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4103\/1008-682X.175785","volume":"18","author":"PG Pilie","year":"2016","unstructured":"Pilie\u00a0PG, Giri\u00a0VN, Cooney\u00a0KA (2016) HOXB13 and other high penetrant genes for prostate cancer. Asian J Androl 18:530\u2013532","journal-title":"Asian J Androl"},{"key":"1491_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard\u00a0CC, Mateo\u00a0J, Walsh\u00a0MF et al (2016) Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N\u00a0Engl J Med 375:443\u2013453","journal-title":"N Engl J Med"},{"key":"1491_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/bju.13310","volume":"117","author":"M Randazzo","year":"2016","unstructured":"Randazzo\u00a0M, M\u00fcller\u00a0A, Carlsson\u00a0S et al (2016) A positive family history as a\u00a0risk factor for prostate cancer in a\u00a0population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int 117:576\u2013583","journal-title":"BJU Int"},{"key":"1491_CR42","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1200\/JCO.2012.44.1238","volume":"31","author":"VM Raymond","year":"2013","unstructured":"Raymond\u00a0VM, Mukherjee\u00a0B, Wang\u00a0F et\u00a0al (2013) Elevated risk of prostate cancer among men with Lynch syndrome. J\u00a0Clin Oncol 31:1713\u20131718","journal-title":"J Clin Oncol"},{"key":"1491_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","volume":"27","author":"TR Rebbeck","year":"2017","unstructured":"Rebbeck\u00a0TR (2017) Prostate cancer genetics: variation by race, ethnicity, and geography. Semin Radiat Oncol 27:3\u201310","journal-title":"Semin Radiat Oncol"},{"key":"1491_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2016.07.032","volume":"99","author":"L Rudichuk","year":"2017","unstructured":"Rudichuk\u00a0L, Vogel\u00a0KJ, Wang\u00a0CH et\u00a0al (2017) Urologists\u2019 current practices in screening and treating men with a\u00a0family history of prostate cancer. Urology 99:180\u2013185","journal-title":"Urology"},{"key":"1491_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2012","unstructured":"Sfanos\u00a0KS, De Marzo\u00a0AM (2012) Prostate cancer and inflammation: the evidence. Histopathology 60:199\u2013215","journal-title":"Histopathology"},{"key":"1491_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/erc.0.0100225","volume":"10","author":"J Simard","year":"2003","unstructured":"Simard\u00a0J, Dumont\u00a0M, Labuda\u00a0D et\u00a0al (2003) Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer 10:225\u2013259","journal-title":"Endocr Relat Cancer"},{"key":"1491_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.seminoncol.2017.02.001","volume":"44","author":"RW Stewart","year":"2017","unstructured":"Stewart\u00a0RW, Lizama\u00a0S, Peairs\u00a0K et\u00a0al (2017) Screening for prostate cancer. Semin Oncol 44:47\u201356","journal-title":"Semin Oncol"},{"key":"1491_CR48","doi-asserted-by":"crossref","unstructured":"Tan SH, Petrovics G, Srivastava S (2018) Prostate cancer genomics: recent advances and the prevailing underrepresentation from racial and ethnic minorities. Int J Mol Sci 19(4):1255","DOI":"10.3390\/ijms19041255"},{"key":"1491_CR49","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bju.13862","volume":"120","author":"JM Telang","year":"2017","unstructured":"Telang\u00a0JM, Lane\u00a0BR, Cher\u00a0ML et\u00a0al (2017) Prostate cancer family history and eligibility for active surveillance: a\u00a0systematic review of the literature. BJU Int 120:464\u2013467","journal-title":"BJU Int"},{"key":"1491_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00345-017-2122-5","volume":"36","author":"M Thalgott","year":"2018","unstructured":"Thalgott\u00a0M, Kron\u00a0M, Brath\u00a0JM et\u00a0al (2018) Men with family history of prostate cancer have a\u00a0higher risk of disease recurrence after radical prostatectomy. World J Urol 36:177\u2013185","journal-title":"World J Urol"},{"key":"1491_CR51","first-page":"4836","volume":"56","author":"SN Thibodeau","year":"1996","unstructured":"Thibodeau\u00a0SN, French\u00a0AJ, Roche\u00a0PC et\u00a0al (1996) Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56:4836\u20134840","journal-title":"Cancer Res"},{"key":"1491_CR52","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1101\/gr.105361.110","volume":"20","author":"NF Wasserman","year":"2010","unstructured":"Wasserman\u00a0NF, Aneas\u00a0I, Nobrega\u00a0MA (2010) An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a\u00a0MYC enhancer. Genome Res 20:1191\u20131197","journal-title":"Genome Res"},{"key":"1491_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrg2507","volume":"10","author":"JS Witte","year":"2009","unstructured":"Witte\u00a0JS (2009) Prostate cancer genomics: towards a\u00a0new understanding. Nat Rev Genet 10:77\u201382","journal-title":"Nat Rev Genet"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-021-01491-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T08:05:38Z","timestamp":1666771538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-021-01491-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1007\/s00120-021-01491-y","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"15 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.H.\u00a0Meissner, M.\u00a0Jahnen und K.\u00a0Herkommer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}